The companies say they will have the most substantial dataset on the DMT molecule in the industry and largest IP portfolio The post Cybin inks agreement...
In big breaking news, Cybin has signed a deal to acquire Small Pharma, giving Cybin an advanced DMT trial. The post Breaking News: Cybin to Acquire...
VR can be used to help prepare for psychedelic therapy, guide them through the journey, and help them integrate experiences. The post Using Virtual Reality...
GH Research has reported its second quarter 2023 financial results, with updates on trials and cash on hand. The post GH Research Reports Q2 2023 Financial...
Today, the idea of psychedelic therapists being required to consume the drugs that they prescribe may seem ridiculous. Not so long ago, it was standard...
The psychedelic industry is changing and growing rapidly. Psychedelic medicines are being catapulted into the mainstream, and these top 10 psychedelic...
An independent review supported earlier positive findings. The post Incannex Seeks FDA Approval for Psilocybin-Assisted Psychotherapy Program appeared...
Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Enveric Biosciences...
Poor mental health affects not only quality of life but performance, resilience and career trajectories of athletes The post Psychedelics may help athletes’...
Despite an overall lack of liquidity, institutional investors - and the FDA - seem more comfortable with psychedelics. The post Institutional Money Picks...